DYCLONE Drug Patent Profile
✉ Email this page to a colleague
When do Dyclone patents expire, and when can generic versions of Dyclone launch?
Dyclone is a drug marketed by Astrazeneca and is included in one NDA.
The generic ingredient in DYCLONE is dyclonine hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dyclonine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DYCLONE?
- What are the global sales for DYCLONE?
- What is Average Wholesale Price for DYCLONE?
Summary for DYCLONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Patent Applications: | 595 |
| DailyMed Link: | DYCLONE at DailyMed |
US Patents and Regulatory Information for DYCLONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | DYCLONE | dyclonine hydrochloride | SOLUTION;TOPICAL | 009925-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Astrazeneca | DYCLONE | dyclonine hydrochloride | SOLUTION;TOPICAL | 009925-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
